MGB-BP-3

DRUG2 trials

Sponsors

MGB Biopharma Limited

Conditions

Clostridium Difficile InfectionHealthy

Phase 1

Safety, Blood Levels and Effects of MGB-BP-3

CompletedNCT02518607

MGB Biopharma LimitedHealthy

Start: 2015-07-31End: 2015-11-30Updated: 2016-03-17

Phase 2

Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD

CompletedNCT03824795

MGB Biopharma LimitedClostridium Difficile Infection

Start: 2019-02-07End: 2020-04-03Updated: 2020-04-15